canSERV relaunches Open Call for Service Provision
- Bild-Infos
- Download
Ein Dokument
CanSERV Open Call for Service Provision relaunches:
EUR 1.000.000 in EU funding available to fast-track cancer therapy development
Graz, 29 August 2024: Starting today, cancer researchers in and outside Europe can apply for complimentary access to over 400 cancer research services to accelerate the entire oncological research developmental pipeline. These services, spanning from basic to clinical science, can be combined to address pertinent research questions. Researchers with oncology-focused proposals are invited to submit their applications by 28 November 2024 via the canSERV project website and the Common Access Management System (CAMS).
Relaunch of the Open Call for Translational Service Provision
As part of a unified effort to address the challenges of cancer, canSERV offers more than 400 world-class customised oncology technologies and state-of-the-art training to cancer researchers worldwide. These services are made available via “Calls for Service Provision”.
The EU Cancer Mission and canSERV
Alongside the growing emphasis on interdisciplinary approaches in cancer research and treatment, the European Union is, as outlined in the 2021 EU Cancer Mission and Europe’s Beating Cancer Plan, committed to accelerating progress in the fight against cancer over the coming decades.
To support this effort, it is essential that Europe’s cancer research community, industry, and citizens have access to the necessary tools and services.
Prof. Jens K. Habermann, Director General of BBMRI-ERIC that is coordinating canSERV, to this project call:
“canSERV bundles research infrastructures, oncology experts, and patient associations to provide the cancer community with the facilities, resources, and services needed in order to enhance personalised treatment approaches. The grants offer a unique chance for cross-domain, interdisciplinary research proposals to come closer to this goal.”
Offering tailored research services to academia and industry
Following the success of the first and second Open Call, the application process has been reopened. canSERV invites applications covering the entire range of the oncology developmental pipeline.
canSERV welcomes excellent research applications addressing at least one of the four strategic goals of the Cancer Mission:
- Understanding of Cancer
- Prevention and Early Detection
- Diagnosis and treatment
- Quality of life for patients and their families
Researchers from academia, industry, and SMEs may apply for several services including:
- Disease models
- Advanced technologies for personalised oncology
- Biomarkers research development and validation
- New therapeutic solutions
- Accelerated translation into personalised oncology clinical practice
- Open digital research services
- Access to human samples and data
- Clinical trials and design
- Ethical, legal and socio-economic dimensions
- Training
Submission details for applicants
Launch date: 29 August 2024
Submission deadline: 28 November 2024, 14.00 CET.
The applications will be reviewed by an international, independent review panel.
The requested services’ timeline should fall within the canSERV project’s duration ( FAQ Section “Time frames for the service provision”). The tentative budget for this first call is EUR 1.0 Mio; the budget may be increased depending on the number of applications. For more information and Call text, please visit our canSERV project website: www.canSERV.eu/Calls
About European Research Infrastructures
European Research Infrastructures (RIs) are organisations that provide the research community with access to specialised facilities, resources, and services, driving scientific progress and promoting sustainable research. Positioned at the heart of the knowledge triangle – research, education, and innovation – RIs have become essential in advancing research and innovation across Europe over the past decade. This project leverages European Life Science research infrastructures to focus on oncology research and innovation, offering support from basic science to clinical translation (from bench to bedside) to advance personalised medicine for cancer patients.
For further information:
canSERV website: www.canserv.eu
Twitter: @canSERV_EU
LinkedIn: canSERV
Project coordination, BBMRI-ERIC:
Prof. Jens K. Habermann, Director General
Judit Balogh, Senior project manager
Press contact, ARTTIC Innovation GmbH:
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.
The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.
ARTTIC Innovation is a one-stop-shop consultancy in public funding and R&I project management as well as communication and stakeholder engagement. We have supported innovative organisations and leading scientists for more than 40 years in navigating the European and national funding ecosystems. ARTTIC Innovation is the reliable partner to work towards improving global health, promoting energy efficiency, safe and clean mobility and aviation, in making societies more resilient, secure, and inclusive and European defense capabilities stronger. At ARTTIC Innovation, we are fully committed to our research clients and partners. We are passionate about their ambitions and help them to innovate and tackle global societal challenges. What unites us all is the desire and ability to innovate sustainably. For more information, please visit www.arttic-innovation.de.
We take your privacy seriously. Click here to read our privacy policy. If you no longer wish to receive emails from us, please click below.